Study Has Revealed the Rise in Antimicrobial Resistance

Photo of author

(Newswire.net — April 1, 2019) Orlando, FL — Urinary tract infections are considered to be the major reason behind the increasing use of antimicrobial medications. While these pharmaceutical drugs are helpful, it is worth mentioning that they can cause side effects.

In a surveillance study, the investigators focused on more than 12 million bacteria. They found that there was E. coli antimicrobial resistance to the most commonly prescribed antimicrobial for UTIs in the United States.

Further in the study, such a resistance has increased over five-fold from 2000 to 2010. They have also discovered that almost one in four isolates were resistant to the second most commonly prescribed drug for UTIs.

This study was published in the Antimicrobial Agents and Chemotherapy. Guillermo Sanchez, primary author of the study, said that the study is essential considering it shows there is E.coli resistance in two common drugs for UTI treatment in over the last decade.

Sanchez is a graduate student in the Physician Assistant program at the George Washington University.He further added what is even more alarming is that there is a lack of new antimicrobial drug development. It is worth mentioning that the E.coli bacteria accounts for 75 percent to 95 percent of all UTI cases.

Urinary tract infections are the most common infections in the world and are more likely to affect women.

The researchers suggest that E.coli antimicrobial resistance is a key factor in learning about the health outcomes in UTI sufferers. It has been linked with reduced clinical cure as well as a heightened risk of infection recurrence.

It is also important to remember that antimicrobial resistance increases significantly the costs of treatment, morbidity, and rates of hospitalization.In addition to antimicrobial resistance, the use of these UTI medications has been found to increase side effect risk. This includes nausea, gastrointestinal distress, and vomiting.

Some safer alternatives are thought to be extremely beneficial against urinary tract infections. One is D-mannose, which continues to gain more and more attention from consumers.

D-mannose is popularized by its ability to inhibit the E.coli bacteria from latching on to the cells lining the urinary tract. When bacteria is able to adhere to these cells, it leads to an infection.

This sugar found in cranberry called D-mannose prevents this from happening. This natural remedy is also widely preferred due to the fact that it can help reduce the rate of antibiotic resistance.

Some researchers have stressed that unlike antibiotics, D-mannose is not harmful to the beneficial bacteria in the body.

Divine Bounty D-mannose may be helpful in preventing and treating UTIs. This amazing formula is highly potent, and is crafted in an FDA-inspected facility in the United States to deliver D-mannose to consumers (http://www.amazon.com/D-Mannose-600mg-Cranberry-Dandelion-Extract/dp/B01LX5KGF0).

About Divine Bounty

Divine Bounty is a family-owned brand that manufactures high-quality turmeric curcumin supplements. Passionate about the potential health benefits of turmeric, the team behind Divine Bounty have carefully researched and sourced only the best ingredients to create the ideal blend of turmeric curcumin. More details are available at http://www.DivineBounty.com.

Divine Bounty

12001 Research Parkway
Suite 236 A
Orlando, FL 32826
United States
(407) 545 7738
media@divinebounty.com
http://www.DivineBounty.com